Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics … Of Peptides and P-ANDAS A Case Study of Taspoglutide
EpiVax_PANDA_Taspoglutide_April_19_Final
Predicting Immunogenicity of Peptide Drugs and Their Impurities Using in Silico Tools: Taspoglutide Case Study
EpiVax_TaspoglutidePoster_14May19
Modeling HLA Binding and “Self” Conservation Using In Silico Tools Predicts Immunogenic T Cell Epitopes in Vaccinated Individuals
EpiVax_ISV2018_HLA Binding and Self Conservation_4Oct18